XM does not provide services to residents of the United States of America.
E
E

EurofinsScientific

News

Glencore, Knaus Tabbert, LSE

EUROPE RESEARCH ROUNDUP- Glencore, Knaus Tabbert, LSE Oct 28 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Glencore, Knaus Tabbert and LSE, on Monday. HIGHLIGHTS * Glencore Plc GLEN.L : HSBC raises to buy from hold * Knaus Tabbert AG KTAG.DE : Jefferies cuts to hold from buy * LSE LSEG.L : RBC raises target price to 11,600p from 11,000p * Suzano SUZB3.SA : HSBC raises to buy from hold * Veolia VIE.PA : RBC initiates coverage with
A
B
D
E
E
E
E
F
G
H
H
H
I
K
R
R
R
S
S
U
V
B
E
S
Y

Eurofins Agrees To Acquire Synlab’S Clinical Diagnostics Operations In Spain

BRIEF-Eurofins Agrees To Acquire Synlab’S Clinical Diagnostics Operations In Spain Oct 28 (Reuters) - EUROFINS SCIENTIFIC SE EUFI.PA : EUROFINS AGREES TO ACQUIRE SYNLAB’S CLINICAL DIAGNOSTICS OPERATIONS IN SPAIN TRANSACTION EXPECTED TO CLOSE IN 2025 PENDING REGULATORY APPROVALS TRANSACTION IS SUBJECT TO CUSTOMARY CONDITIONS, INCLUDING REGULATOR
E

European shares sag, SAP boosts tech stocks after forecast raise

UPDATE 2-European shares sag, SAP boosts tech stocks after forecast raise For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. SAP hits record high Randstad, DNB climb after Q3 profit beat Eurofins, Munters at the bottom of STOXX 600 IMF cuts forecasts for German economy this year and next Updated at 1605 GMT By Paolo Laudani, Ankika Biswas and Johann M Cherian Oct 22 (Reuters) - European stocks slipped on Tuesday, as investors navigated geo
E
L
S
R
G
E
F
I
S
S
G

Weak start for STOXX, tech caps further losses

LIVE MARKETS-Weak start for STOXX, tech caps further losses STOXX 600 flat Tech names best off Utilities drag HSBC announces overhaul Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com WEAK START FOR STOXX, TECH CAPS FURTHER LOSSES Europe's STOXX 600 .STOXX is down a tiny 0.02%, as traders maintain a cautious attitude with an eye on the looming U.S.
E
E
H
S
E
E
F
U
G

Eurofins shares plunge after organic growth target miss, outlook change

BUZZ-Eurofins shares plunge after organic growth target miss, outlook change ** Shares of Eurofins Scientific EUFI.PA falls over 9% after the company reports nine-month growth below its guidance, hitting the bottom of STOXX .STOXX index ** The group's nine-month organic sales growth of 5.2% on a reported basis places it below its mid-term guidance
E

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.